Forian target of $2.17 per-share cash tender offer
Forian Inc. has been the target of a cash tender offer by Bravo Merger Sub, Inc., a subsidiary of 2025 Acquisition Company, LLC, to purchase all issued and outstanding common shares for $2.17 per Share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Forian Inc. has been the target of a cash tender offer by Bravo Merger Sub, Inc., a subsidiary of 2025 Acquisition Company, LLC, to purchase all issued and outstanding common shares for $2.17 per Share. The Offer to Purchase is dated April 16, 2026 and is filed on Schedule TO. According to the filing, there were 31,241,760 Shares issued and outstanding as of March 31, 2026.
The tender does not include Shares already owned by the buyer parties (the "Excluded Shares") and is being made on the terms set forth in the Offer to Purchase and the Letter of Transmittal, each incorporated by reference. The Agreement and Plan of Merger dated April 2, 2026 is attached as an exhibit and governs the back-end merger mechanics.
Insights
Buyer files a cash tender offer at $2.17 per share to acquire all outstanding common stock.
The filing shows a going-private transaction structure: a public tender offer dated April 16, 2026 and a related Merger Agreement dated April 2, 2026. The offer price is $2.17 per Share, and the public float reported is 31,241,760 Shares as of March 31, 2026.
Key dependencies include acceptance levels, any conditions in the Offer to Purchase (including financing conditions referenced in the filing), and treatment of Excluded Shares. Subsequent tender results and any satisfaction or waiver of sale conditions will determine whether the merger proceeds to closing.
Transaction is cash-funded with an attached Equity Commitment Letter and contribution agreements noted.
The Schedule TO references an Equity Commitment Letter and a Contribution Agreement among buyers and certain shareholders (exhibits cited). The Offer to Purchase includes sections on "Source and Amount of Funds" and "Fees and Expenses," indicating disclosed financing arrangements.
Investors will watch the Offer to Purchase sections for any financing conditions or termination rights and the tender acceptance thresholds required to effect the merger.
Key Figures
Key Terms
Schedule TO regulatory
Tender Offer financial
Agreement and Plan of Merger legal
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What price is the Forian (FORA) tender offer at?
Who is making the tender offer for Forian (FORA)?
Is there a merger agreement tied to the tender offer?
Where can I find financing and fund source details for the offer?
AI-generated analysis. How Rhea-AI works. Not financial advice.